-
1
Guiding the Clinical Nurse Specialist role in oncology within Princess Margaret Cancer Centre
Published 2022-07-01“…In response to the CNA publication, the CNS Community of Practice (CoP) at Princess Margaret Cancer Centre (PM) reviewed how the oncology CNS roles at PM aligned with the CNA competencies. …”
Get full text
Article -
2
P548: Universal germline genetic testing for breast cancer at the Princess Margaret Cancer Centre
Published 2024-01-01Get full text
Article -
3
Pivoting the Provision of Smoking Cessation Education in a Virtual Clinical World: The Princess Margaret Cancer Centre Experience
Published 2021-12-01“…Here, we describe how the Princess Margaret Cancer Centre implemented innovative solutions to improve the delivery of education during the COVID-19 pandemic to better support patients and healthcare providers.…”
Get full text
Article -
4
The Survival Outcomes of the Metastatic Nonclear Cell Renal Cell Carcinoma in the Immunotherapy Era: Princess Margaret Cancer Centre Experience
Published 2024-03-01“…Here, we report survival outcomes for patients with metastatic nccRCC treated with IO and/or TT at the Princess Margaret Cancer Centre, Toronto, ON, Canada. Demographics, disease characteristics, and survival outcomes were collected retrospectively. …”
Get full text
Article -
5
-
6
-
7
Fcmr regulates mononuclear phagocyte control of anti-tumor immunity
Published 2019-06-01Get full text
Article -
8
-
9
-
10
Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer
Published 2020-01-01Get full text
Article -
11
-
12
First impressions: A prospective evaluation of patient–physician concordance and satisfaction following the initial medical oncology consultation
Published 2023-12-01“…Methods Between January and August 2021, patients without prior systemic treatment of their gastrointestinal malignancy (GI) attending the Princess Margaret Cancer Centre (PMCC) were approached within 24 h of their initial consultation to complete a paper‐based questionnaire assessing understanding of their disease (diagnosis, treatment plan/intent, and prognosis) and satisfaction with the consultation. …”
Get full text
Article -
13
P1040: FACTORS ASSOCIATED WITH THROMBOSIS IN MYELOFIBROSIS
Published 2023-08-01Get full text
Article -
14
-
15
-
16
Biological and therapeutic implications of a unique subtype of NPM1 mutated AML
Published 2021-02-01Get full text
Article -
17
Author Correction: Gene isoforms as expression-based biomarkers predictive of drug response in vitro
Published 2018-01-01Get full text
Article -
18
Functional profiling of single CRISPR/Cas9-edited human long-term hematopoietic stem cells
Published 2019-10-01Get full text
Article -
19
-
20